Výsledky vyhľadávania - "HIV Integrase Inhibitors/administration"

Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the SALSA Study

Autori: Princy Kumar Amanda E. Clarke Celia Jonsson-Oldenbüttel a ďalší

Zdroj: AIDS Behav
AIDS AND BEHAVIOR
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
Fundación de Investigación del Hospital General de Valencia (FIHGUV)

Predmety: Male, Adult, Original Paper, Pyridones, Anti-HIV Agents, Lamivudine, Surveys and Questionnaires [MeSH], HIV Treatment Satisfaction Questionnaire, Drug Combinations [MeSH], HIV-1 [MeSH], Patient Satisfaction/statistics, Anti-HIV Agents/therapeutic use [MeSH], Piperazines [MeSH], Dolutegravir, Male [MeSH], Treatment experienced, Anti-HIV Agents/administration, Female [MeSH], HIV Infections/psychology [MeSH], Health-related quality of life, Adult [MeSH], HIV Symptom Distress Module, Humans [MeSH], Treatment Outcome [MeSH], HIV Integrase Inhibitors/therapeutic use [MeSH], Oxazines [MeSH], Lamivudine/administration, Middle Aged [MeSH], Viral Load [MeSH], Patient Reported Outcome Measures [MeSH], Heterocyclic Compounds, 3-Ring/therapeutic use [MeSH], Heterocyclic Compounds, 3-Ring/administration, HIV Integrase Inhibitors/administration, HIV Infections/drug therapy [MeSH], Lamivudine/therapeutic use [MeSH], Pyridones [MeSH], HIV Infections, Middle Aged, Viral Load, Piperazines, Drug Combinations, Treatment Outcome, Patient Satisfaction, Surveys and Questionnaires, Oxazines, HIV-1, Humans, Female, Patient Reported Outcome Measures, HIV Integrase Inhibitors, Heterocyclic Compounds, 3-Ring

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39225890
https://fihguv.fundanetsuite.com/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2520
https://repository.publisso.de/resource/frl:6494294

Sustained viral suppression with once daily dolutegravir-containing regimen in presence of the strong inducer carbamazepine

Autori: Micol Pallanza Paul Thoueille Myriam Briki a ďalší

Zdroj: Antiviral therapy, vol. 30, no. 2, pp. 13596535251335080

Predmety: Male, Adult, Sustained Virologic Response, Pyridones, Humans, Oxazines, Piperazines, Heterocyclic Compounds, 3-Ring/administration & dosage, Heterocyclic Compounds, 3-Ring/therapeutic use, HIV Infections/drug therapy, HIV Infections/virology, Carbamazepine/therapeutic use, Carbamazepine/administration & dosage, HIV Integrase Inhibitors/administration & dosage, HIV Integrase Inhibitors/therapeutic use, Drug Interactions, Drug Monitoring, HIV-1/drug effects, Viral Load/drug effects, HIV, carbamazepine, dolutegravir, once daily, plasma levels, strong inducer, HIV Infections, Viral Load, Carbamazepine, HIV-1, HIV Integrase Inhibitors, Heterocyclic Compounds, 3-Ring

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/40230016
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_94CAA7C420227
https://serval.unil.ch/resource/serval:BIB_94CAA7C42022.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_94CAA7C42022

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

Autori: Willem D.F. Venter Michelle Moorhouse Simiso Sokhela a ďalší

Prispievatelia: Willem D.F. Venter Michelle Moorhouse Simiso Sokhela a ďalší

Zdroj: New England Journal of Medicine. 381:803-815

Predmety: Male, Phosphorous Acids, Clinical Trial, Phase III, HIV Infections, GUIDELINES, RECOMMENDATIONS, Piperazines, Anti-Retroviral Agents/administration & dosage, ANTIRETROVIRAL THERAPY, PROGRAMS, Heterocyclic Compounds, Bone Density, Pregnancy, INFECTION, Prodrugs, Viral, Pregnancy Complications, Infectious, 11 Medical and Health Sciences, Research Support, Non-U.S. Gov't, Infectious, General Medicine, Viral Load, Middle Aged, Intention to Treat Analysis, 3. Good health, Anti-Retroviral Agents, OBESITY, Combination, Randomized Controlled Trial, Medicine, RNA, Viral, Drug Therapy, Combination, Female, Life Sciences & Biomedicine, Heterocyclic Compounds, 3-Ring, Adult, HIV-1/genetics, Adolescent, HIV Infections/drug therapy, General & Internal, 3-Ring, EFAVIRENZ, Young Adult, Medicine, General & Internal, Prodrugs/administration & dosage, Drug Therapy, General & Internal Medicine, Oxazines, Journal Article, Humans, Adenine/administration & dosage, Comparative Study, RNA, Viral/blood, HIV Integrase Inhibitors, Uracil, Science & Technology, Uracil/administration & dosage, Adenine, Heterocyclic Compounds, 3-Ring/administration & dosage, Pregnancy Complications, Infectious/drug therapy, Bone Density/drug effects, ADULTS, Phosphorous Acids/administration & dosage, EFFICACY, RISKS, CD4 Lymphocyte Count, Pregnancy Complications, HIV Integrase Inhibitors/administration & dosage, HIV-1, RNA

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/31339677
https://europepmc.org/abstract/MED/31339677
https://pesquisa.bvsalud.org/portal/resource/pt/mdl-31339677
https://www.nejm.org/doi/full/10.1056/NEJMoa1902824
https://dspace.library.uu.nl/handle/1874/389279
https://www.narcis.nl/publication/RecordID/oai%3Adspace.library.uu.nl%3A1874%2F389279
https://pubmed.ncbi.nlm.nih.gov/31339677/
https://dspace.library.uu.nl/handle/1874/389279
http://hdl.handle.net/10044/1/81878

Dolutegravir as a trigger for DRESS syndrome?

Autori: Martin, Charlotte Payen, Marie-Christine De Wit, Stéphane

Zdroj: International Journal of STD & AIDS. 29:1036-1038

Predmety: Male, 0301 basic medicine, Anti-HIV Agents, Pyridones, Exanthema -- chemically induced, Antiretroviral Therapy, Eosinophilia -- chemically induced, Pharmacologie, Santé publique, Piperazines, 03 medical and health sciences, Fatal Outcome, 0302 clinical medicine, Heterocyclic Compounds, HIV Integrase Inhibitors -- administration & dosage -- adverse effects, Antiretroviral Therapy, Highly Active, Eosinophilia, Oxazines, Humans, Highly Active, Drug Interactions, HIV Integrase Inhibitors, Pathologie maladies infectieuses, Dermatologie, human immunodeficiency virus, toxicity, Exanthema, Middle Aged, Anti-HIV Agents -- administration & dosage -- adverse effects, Drug Hypersensitivity Syndrome -- diagnosis, dolutegravir, 3. Good health, 3-Ring -- administration & dosage -- adverse effects, Drug Hypersensitivity Syndrome, Heterocyclic Compounds, 3-Ring

Popis súboru: No full-text files

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/29621952
http://journals.sagepub.com/doi/10.1177/0956462418764973
https://journals.sagepub.com/doi/10.1177/0956462418764973
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/287665/Details
https://www.ncbi.nlm.nih.gov/pubmed/29621952
https://pubmed.ncbi.nlm.nih.gov/29621952/

Hit me with your best shot: dolutegravir – a space in the next WHO guidelines?

Autori: Cohn, Jennifer Bekker, Linda-Gail Bygrave, Helen a ďalší

Zdroj: AIDS. 29:2067-2070

Predmety: Clinical Trials as Topic, Pyridones, Heterocyclic Compounds, 3-Ring / administration & dosage, HIV Infections, Antiretroviral Therapy, Highly Active / methods, HIV Integrase Inhibitors / administration & dosage, HIV Infections / drug therapy, Piperazines, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Antiretroviral Therapy, Highly Active, Oxazines, Humans, HIV Integrase Inhibitors, Heterocyclic Compounds, 3-Ring

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/26544574
http://www.ncbi.nlm.nih.gov/pubmed/26544574
http://europepmc.org/abstract/MED/26544574

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

Autori: Turkova, Anna White, Ellen Mujuru, Hilda a ďalší

Prispievatelia: Turkova, Anna White, Ellen Mujuru, Hilda a ďalší

Zdroj: ISSN: 0028-4793.

Predmety: MESH: Administration, Oral, MESH: Adolescent, MESH: HIV Infections / virology, MESH: HIV Integrase Inhibitors / administration & dosage, MESH: Alkynes / therapeutic use, MESH: Anti-Retroviral Agents / adverse effects, MESH: Anti-Retroviral Agents / therapeutic use, MESH: Benzoxazines / therapeutic use, MESH: Child, Preschool, MESH: Cholesterol / blood, MESH: Cyclopropanes / therapeutic use, MESH: Drug Therapy, Combination, MESH: Female, MESH: HIV Infections / drug therapy, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie

Relation: info:eu-repo/semantics/altIdentifier/pmid/34965338; PUBMED: 34965338; PUBMEDCENTRAL: PMC7614690

Dostupnosť: https://hal.science/hal-04682062
https://doi.org/10.1056/NEJMoa2108793

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

Autori: Venter, Willem D F Moorhouse, Michelle Sokhela, Simiso a ďalší

Prispievatelia: Venter, Willem D F Moorhouse, Michelle Sokhela, Simiso a ďalší

Predmety: Adenine/administration & dosage, Adolescent, Adult, Anti-Retroviral Agents/administration & dosage, Bone Density/drug effects, CD4 Lymphocyte Count, Drug Therapy, Combination, Female, HIV Infections/drug therapy, HIV Integrase Inhibitors/administration & dosage, HIV-1/genetics, Heterocyclic Compounds, 3-Ring/administration & dosage, Humans, Intention to Treat Analysis, Male, Middle Aged, Phosphorous Acids/administration & dosage, Pregnancy, Pregnancy Complications, Infectious/drug therapy, Prodrugs/administration & dosage, RNA, Viral/blood, Uracil/administration & dosage, Viral Load, Young Adult, General Medicine, Research Support

Popis súboru: application/pdf

Relation: https://dspace.library.uu.nl/handle/1874/389279

Dostupnosť: https://dspace.library.uu.nl/handle/1874/389279

Tivicay (dolutegravir) / Tivicay (dolutegravir)

Autori: Anonymous

Zdroj: Information från Läkemedelsverket. 25(4):53